Cadazolid

N/A

Report date: 2026/03/04 20:01:44
NMEQIDP

Base Information

Drug NameCadazolid
Drug Alias Name卡达唑烷Cadazolidum卡达唑利德卡达唑胺ACT-179811 +[6] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Oxazolidinone antibioticsSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionProtein synthesis inhibitorsBacterial DNA gyrase inhibitors
TargetsBacterial DNA gyrase
Therapy Area/IndicationsClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[13] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesActelion Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesActelion Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsClostridium Infections

Other Information

ATC CodeN/A
Related LinksWikipedia